POLYPID LTD (PYPD) Stock Price, Forecast & Analysis
USA - NASDAQ:PYPD - IL0011326795 - Common Stock
PYPD Key Statistics, Chart & Performance
The current stock price of PYPD is 3.79 USD. In the past month the price increased by 10.5%. In the past year, price increased by 6.76%.
PYPD Latest News, Press Relases and Analysis
PYPD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 42.1 | 876.24B | ||
| JNJ | JOHNSON & JOHNSON | 17.92 | 447.95B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.28 | 251.61B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.02 | 242.95B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 12.62 | 215.33B | ||
| MRK | MERCK & CO. INC. | 9.58 | 210.79B | ||
| PFE | PFIZER INC | 7.69 | 139.92B | ||
| SNY | SANOFI-ADR | 11.21 | 119.42B | ||
| GSK | GSK PLC-SPON ADR | 7.73 | 93.91B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.08 | 94.59B | ||
| ZTS | ZOETIS INC | 19 | 53.40B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 194.14 | 42.92B |
Related stock screener links
About PYPD
Company Profile
PolyPid Ltd. operates as a phase 3 biopharma company. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Company Info
POLYPID LTD
18 Hasivim Street, P.O Box 7126
Petah Tikva 49537 IL
CEO: Amir Weisberg
Employees: 59
Phone: 972747195700
POLYPID LTD / PYPD FAQ
What does PYPD do?
PolyPid Ltd. operates as a phase 3 biopharma company. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
What is the stock price of POLYPID LTD today?
The current stock price of PYPD is 3.79 USD. The price decreased by -1.3% in the last trading session.
What is the dividend status of POLYPID LTD?
PYPD does not pay a dividend.
What is the ChartMill rating of POLYPID LTD stock?
PYPD has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the sector and industry classification for POLYPID LTD?
POLYPID LTD (PYPD) operates in the Health Care sector and the Pharmaceuticals industry.
What is the next earnings date for PYPD stock?
POLYPID LTD (PYPD) will report earnings on 2025-11-12, before the market open.
Can you provide the short interest for PYPD stock?
The outstanding short interest for POLYPID LTD (PYPD) is 0.46% of its float.
PYPD Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to PYPD. When comparing the yearly performance of all stocks, PYPD is one of the better performing stocks in the market, outperforming 75.64% of all stocks.
PYPD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PYPD. The financial health of PYPD is average, but there are quite some concerns on its profitability.
PYPD Financial Highlights
Over the last trailing twelve months PYPD reported a non-GAAP Earnings per Share(EPS) of -3.79. The EPS increased by 62.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -90.87% | ||
| ROE | -172.65% | ||
| Debt/Equity | 0 |
PYPD Forecast & Estimates
10 analysts have analysed PYPD and the average price target is 12.75 USD. This implies a price increase of 236.41% is expected in the next year compared to the current price of 3.79.